Tianmei Biotech (BON)
Yangkang Asset, in partnership with Tiger Brokers, successfully assisted Tianmei Biotech (BON) in listing on the Nasdaq Capital Market in the United States, raising 27.85 million USD and becoming a prominent representative of Asia’s health biotech sector entering the international market.
Tianmei Biotech (BON) Read More »